1.
Pinto LC, Sales L de O, Azevedo TC de B, Moreira-Nunes CA, Lemos JAR. BCR-ABL kinase domain mutations analysis in chronic myeloid leukaemia patients that are not responsive to imatinib mesylate. HSJ [Internet]. 2020 Dec. 10 [cited 2024 Nov. 4];10(4):77-84. Available from: https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/994